351 related articles for article (PubMed ID: 24891400)
1. Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P).
Potì F; Simoni M; Nofer JR
Cardiovasc Res; 2014 Aug; 103(3):395-404. PubMed ID: 24891400
[TBL] [Abstract][Full Text] [Related]
2. [Measurement of sphingosine 1-phosphate as a biomarker of atherosclerosis].
Kimura T; Okajima F; Murakami M
Rinsho Byori; 2007 Apr; 55(4):358-62. PubMed ID: 17511266
[TBL] [Abstract][Full Text] [Related]
3. Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice.
Feuerborn R; Besser M; Potì F; Burkhardt R; Weißen-Plenz G; Ceglarek U; Simoni M; Proia RL; Freise H; Nofer JR
Thromb Haemost; 2018 Aug; 118(8):1470-1480. PubMed ID: 30060257
[TBL] [Abstract][Full Text] [Related]
4. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K
Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219
[TBL] [Abstract][Full Text] [Related]
5. [The role of apolipoprotein M and sphingosine 1-phosphate axis in the prevention of atherosclerosis].
Nádró B; Juhász L; Szentpéteri A; Páll D; Paragh G; Harangi M
Orv Hetil; 2018 Feb; 159(5):168-175. PubMed ID: 29376427
[TBL] [Abstract][Full Text] [Related]
6. SKI-II--a sphingosine kinase 1 inhibitor--exacerbates atherosclerosis in low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet.
Potì F; Ceglarek U; Burkhardt R; Simoni M; Nofer JR
Atherosclerosis; 2015 May; 240(1):212-5. PubMed ID: 25801013
[TBL] [Abstract][Full Text] [Related]
7. Serum-Sphingosine-1-Phosphate Concentrations Are Inversely Associated with Atherosclerotic Diseases in Humans.
Soltau I; Mudersbach E; Geissen M; Schwedhelm E; Winkler MS; Geffken M; Peine S; Schoen G; Debus ES; Larena-Avellaneda A; Daum G
PLoS One; 2016; 11(12):e0168302. PubMed ID: 27973607
[TBL] [Abstract][Full Text] [Related]
8. Dynamic changes of the composition of plasma HDL particles in patients with cardiac disease: Spotlight on sphingosine-1-phosphate/serum amyloid A ratio.
Egom EE; Shiwani HA; Pharithi RB; Canning R; Khan B; Hiani YE; Maher V
Clin Exp Pharmacol Physiol; 2018 Apr; 45(4):319-325. PubMed ID: 29112769
[TBL] [Abstract][Full Text] [Related]
9. Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids.
Nofer JR; Assmann G
Trends Cardiovasc Med; 2005 Oct; 15(7):265-71. PubMed ID: 16226682
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin.
Rodríguez C; González-Díez M; Badimon L; Martínez-González J
Thromb Haemost; 2009 Apr; 101(4):665-73. PubMed ID: 19350109
[TBL] [Abstract][Full Text] [Related]
11. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA
Circulation; 2007 Jan; 115(4):501-8. PubMed ID: 17242282
[TBL] [Abstract][Full Text] [Related]
12. The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality.
Prüfer N; Kleuser B; van der Giet M
Biol Chem; 2015 Jun; 396(6-7):573-83. PubMed ID: 25252751
[TBL] [Abstract][Full Text] [Related]
13. The relationship between the high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) and coronary in-stent restenosis.
Jing XD; Wei XM; Deng SB; Du JL; Liu YJ; She Q
Clin Chim Acta; 2015 Jun; 446():248-52. PubMed ID: 25958848
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
Sattler KJ; Elbasan S; Keul P; Elter-Schulz M; Bode C; Gräler MH; Bröcker-Preuss M; Budde T; Erbel R; Heusch G; Levkau B
Basic Res Cardiol; 2010 Nov; 105(6):821-32. PubMed ID: 20652276
[TBL] [Abstract][Full Text] [Related]
15. Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate.
Dueñas AI; Aceves M; Fernández-Pisonero I; Gómez C; Orduña A; Crespo MS; García-Rodríguez C
Cardiovasc Res; 2008 Aug; 79(3):537-44. PubMed ID: 18411230
[TBL] [Abstract][Full Text] [Related]
16. Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I.
Okajima F; Sato K; Kimura T
Endocr J; 2009; 56(3):317-34. PubMed ID: 18753704
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model.
Krishna SM; Seto SW; Moxon JV; Rush C; Walker PJ; Norman PE; Golledge J
Am J Pathol; 2012 Aug; 181(2):706-18. PubMed ID: 22698985
[TBL] [Abstract][Full Text] [Related]
18. Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.
Sattler K; Gräler M; Keul P; Weske S; Reimann CM; Jindrová H; Kleinbongard P; Sabbadini R; Bröcker-Preuss M; Erbel R; Heusch G; Levkau B
J Am Coll Cardiol; 2015 Sep; 66(13):1470-85. PubMed ID: 26403344
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection.
Sattler K; Levkau B
Cardiovasc Res; 2009 May; 82(2):201-11. PubMed ID: 19233866
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function.
Malchinkhuu E; Sato K; Muraki T; Ishikawa K; Kuwabara A; Okajima F
Biochem J; 2003 Mar; 370(Pt 3):817-27. PubMed ID: 12470300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
